The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial

Nicotine and Tobacco Research

Volumn 9, Issue 2, 2007, Pages 225-231

  David, Sean P ^a,b   Munafò, Marcus R ^c   Murphy, Michael F G ^b   Walton, Robert T ^d   Johnstone, Elaine C ^b  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH; PLACEBO; SEROTONIN TRANSPORTER; NICOTINE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; TREATMENT OUTCOME; UNITED KINGDOM; GENETICS; SMOKING;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NICOTINE; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 34047205168     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200601078566     Document Type: Article

References (40)

1. Battersby, S., Ogilvie, A. D., Blackwood, D. H., Shen, S., Muqit, M. M., Muir, W. J., Teague, P., Goodwin, G. M. and Harmar, A. J. (1999) Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene. Journal of Neurochemistry, 72, pp. 1384-1388.
2. Bengel, D., Greenberg, B. D., Cora-Locatelli, G., Altemus, M., Heils, A., Li, Q. and Murphy, D. L. (1999) Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Molecular Psychiatry, 4, pp. 463-466.
3. Cardon, L. R., Idury, R. M., Harris, T. J., Witte, J. S. and Elston, R. C. (2000) Testing drug response in the presence of genetic information: Sampling issues for clinical trials. Pharmacogenetics, 10, pp. 503-510.
4. Curran, S., Purcell, S., Craig, I., Asherson, P. and Sham, P. (2005) The serotonin transporter gene as a QTL for ADHD. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 134, pp. 42-47.
5. Dahl, J. P., Jepson, C., Levenson, R., Wileyto, E. P., Patterson, F., Berrettini, W. H. and Lerman, C. (2006) Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics Journal, 6, pp. 194-199.
6. David, S. P., Murthy, N. V., Rabiner, E. A., Munafö, M. R., Johnstone, E. C., Jacob, R., Walton, R. T. and Grasby, P. M. (2005) A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1a receptor binding in humans. Journal of Neuroscience, 25, pp. 2586-2590.
7. Du, L., Faludi, G., Palkovits, M., Demeter, E., Bakish, D., Lapierre, Y. D., Sotonyi, P. and Hrdina, P. D. (1999) Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biological Psychiatry, 46, pp. 196-201.
8. Fan, J. B. and Sklar, P. (2005) Meta-analysis reveals association between serotonin transporter gene stin2 VNTR polymorphism and schizophrenia. Molecular Psychiatry, 10, pp. 928-938.
9. Flattem, N. L. and Blakely, R. D. (2000) Modified structure of the human serotonin transporter promoter. Molecular Psychiatry, 5, pp. 110-115.
10. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. and Fagerström, K. O. (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, pp. 1119-1127.
11. Heils, A., Mossner, R. and Lesch, K. P. (1997) The human serotonin transporter gene polymorphism - Basic research and clinical implications. Journal of Neural Transmission, 104, pp. 1005-1014.
12. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D. and Lesch, K. P. (1996) Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66, pp. 2621-2624.
13. Hu, X., Oroszi, G., Chun, J., Smith, T. L., Goldman, D. and Schuckit, M. A. (2005) An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcoholism, Clinical and Experimental Research, 29, pp. 8-16.
14. Imperial Cancer Research Fund General Practice Research Group (1993) Effectiveness of a nicotine patch in helping people stop smoking: Results of a randomised trial in general practice. British Medical Journal, 306, pp. 1304-1308.
15. Imperial Cancer Research Fund General Practice Research Group (1994) Randomised trial of nicotine patches in general practice: Results at one year. British Medical Journal, 308, pp. 1476-1477.
16. Johnstone, E. C., Yudkin, P. L., Hey, K., Roberts, S. J., Welch, S. J., Murphy, M. F., Griffiths, S. E. and Walton, R. T. (2004) Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics, 14, pp. 83-90.
17. Kent, L., Doerry, U., Hardy, E., Parmar, R., Gingell, K., Hawi, Z., Kirley, A., Lowe, N., Fitzgerald, M., Gill, M. and Craddock, N. (2002) Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): Analysis and pooled analysis. Molecular Psychiatry, 7, pp. 908-912.
18. Lasky-Su, J. A., Faraone, S. V., Glatt, S. J. and Tsuang, M. T. (2005) Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 133, pp. 110-115.
19. Lee, M., Bailer, U. F., Frank, G. K., Henry, S. E., Meltzer, C. C., Price, J. C., Mathis, C. A., Putnam, K. T., Ferrell, R. E., Hariri, A. R. and Kaye, W. H. (2005) Relationship of a 5-HT transporter functional polymorphism to 5-HT(1a) receptor binding in healthy women. Molecular Psychiatry, 10, pp. 715-716.
20. Lerman, C., Caporaso, N. E., Audrain, J., Main, D., Boyd, N. R. and Shields, P. G. (2000) Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry, 5, pp. 189-192.
21. Lerman, C., Jepson, C., Wileyto, E. P., Epstein, L. H., Rukstalis, M., Patterson, F., Kaufmann, V., Restine, S., Hawk, L., Niaura, R. and Berrettini, W. (2006) Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials. Neuropsychopharmacology, 31, pp. 231-242.
22. Lerman, C., Wileyto, E. P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Restine, S., Shields, P. G., Kaufmann, V., Redden, D., Benowitz, N. and Berrettini, W. H. (2004) The functional mu opioid receptor (OPRM1) asn40asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics Journal, 4, pp. 184-192.
23. Lesch, K. P., Balling, U., Gross, J., Strauss, K., Wolozin, B. L., Murphy, D. L. and Riederer, P. (1994) Organization of the human serotonin transporter gene. Journal of Neural Transmission: Genetics Section, 95, pp. 157-162.
24. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H. and Murphy, D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, pp. 1527-1531.
25. Lesch, K. P. and Gutknecht, L. (2005) Pharmacogenetics of the serotonin transporter. Progress in Neuro-psychopharmacology & Biological Psychiatry, 29, pp. 1062-1073.
26. Lesch, K. P., Jatzke, S., Meyer, J., Stober, G., Okladnova, O., Mossner, R. and Riederer, P. (1999) Mosaicism for a serotonin transporter gene promoter-associated deletion: Decreased recombination in depression. Journal of Neural Transmission, 106, pp. 1223-1230.
27. Lesch, K. P., Wolozin, B. L., Estler, H. C., Murphy, D. L. and Riederer, P. (1993) Isolation of a cDNA encoding the human brain serotonin transporter. Journal of Neural Transmission: Genetics Section, 91, pp. 67-72.
28. Li, M. D., Cheng, R., Ma, J. Z. and Swan, G. E. (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction, 98, pp. 23-31.
29. Li, Q., Wichems, C., Heils, A., Lesch, K. P. and Murphy, D. L. (2000) Reduction in the density and expression, but not g-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: Gender and brain region differences. Journal of Neuroscience, 20, pp. 7888-7895.
30. Little, K. Y., McLaughlin, D. P., Zhang, L., Livermore, C. S., Dalack, G. W., McFinton, P. R., DelProposto, Z. S., Hill, E., Cassin, B. J., Watson, S. J. and Cook, E. H. (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American Journal of Psychiatry, 155, pp. 207-213.
31. Malaiyandi, V., Lerman, C., Benowitz, N. L., Jepson, C., Patterson, F. and Tyndale, R. F. (2006) Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry, 11, pp. 400-409.
32. Munafò, M. R., Bradburn, M., Bowes, L. and David, S. (2004) Investigating subgroups in smoking cessation treatment response. Nicotine & Tobacco Research, 6, pp. 865-867.
33. Munafò, M. R., Clark, T., Johnstone, E., Murphy, M. and Walton, R. (2004) The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine & Tobacco Research, 6, pp. 583-597.
34. Munafò, M. R., Clark, T. G., Moore, L. R., Payne, E., Walton, R. and Flint, J. (2003) Genetic polymorphisms and personality in healthy adults: A systematic review and meta-analysis. Molecular Psychiatry, 8, pp. 471-484.
35. Munafò, M. R., Johnstone, E. C., Wileyto, E. P., Shields, P. G., Elliot, K. M. and Lerman, C. (2006) Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology, Biomarkers and Prevention, 15, pp. 398-400.
36. Murphy, D. L., Lerner, A., Rudnick, G. and Lesch, K. P. (2004) Serotonin transporter: Gene, genetic disorders, and pharmacogenetics. Molecular Interventions, 4:2, pp. 109-123.
37. Olausson, P., Engel, J. A. and Soderpalm, B. (1999) Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram. Psychopharmacology, 142, pp. 111-119.
38. Sen, S., Burmeister, M. and Ghosh, D. (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 127, pp. 85-89.
39. Veenstra-VanderWeele, J., Anderson, G. M. and Cook Jr., E. H. (2000) Pharmacogenetics and the serotonin system: Initial studies and future directions. European Journal of Pharmacology, 410, pp. 165-181.
40. Yudkin, P., Munafò, M., Hey, K., Roberts, S., Welch, S., Johnstone, E., Murphy, M., Griffiths, S. and Walton, R. (2004) Effectiveness of nicotine patches in relation to genotype in women versus men: Randomised controlled trial. British Medical Journal, 328, pp. 989-990.